D.E. Shaw & Co’s Amedisys AMED Stock Holding History

D.E. Shaw & Co’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,500	Closed	-$344K	–	4532
2025 Q2	$344K	Hold	3,500	–	–	﹤0.01%	3806
2025 Q1	$324K	Hold	3,500	–	–	﹤0.01%	3731
2024 Q4	$318K	Buy	+3,500	New	+$321K	﹤0.01%	3857
2022 Q2	–	Sell	-10,000	Closed	-$1.72M	–	5311
2022 Q1	$1.72M	Sell	10,000 -1,500	-13%	-$224K	﹤0.01%	3444
2021 Q4	$1.86M	Buy	+11,500	New	+$1.85M	﹤0.01%	3414
2020 Q3	–	Sell	-10,000	Closed	-$1.99M	–	3797
2020 Q2	$1.99M	Hold	10,000	–	–	﹤0.01%	2410
2020 Q1	$1.83M	Buy	+10,000	New	+$1.78M	﹤0.01%	2237
2019 Q1	–	Sell	-13,000	Closed	-$1.52M	–	3568
2018 Q4	$1.52M	Buy	+13,000	New	+$1.53M	﹤0.01%	2369
2015 Q1	–	Sell	-20,000	Closed	-$587K	–	3604
2014 Q4	$587K	Hold	20,000	–	–	﹤0.01%	3211
2014 Q3	$403K	Buy	+20,000	New	+$386K	﹤0.01%	3512
2014 Q1	–	Sell	-20,000	Closed	-$293K	–	4250
2013 Q4	$293K	Hold	20,000	–	–	﹤0.01%	4071
2013 Q3	$344K	Buy	+20,000	New	+$297K	﹤0.01%	3825

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

MCI

MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

D.E. Shaw & Co's AMED Position: Q3 2024 in Review

D.E. Shaw & Co sold out of Amedisys (AMED) in Q3 2024, closing a stake of 3,078 shares — an estimated $283K sold.

D.E. Shaw & Co first reported a position in AMED in Q2 2013 and held it in 45 quarters. The position peaked at $97.4M in Q3 2021. 285 funds tracked by Wall St. Rank hold AMED as of Q3 2024.

D.E. Shaw & Co reported no remaining Amedisys position as of Q3 2024 after selling out during the quarter.
D.E. Shaw & Co sold 3,078 Amedisys shares in Q3 2024, an estimated $283K.
D.E. Shaw & Co first reported a position in Amedisys in Q2 2013 and held it in 45 quarters.
D.E. Shaw & Co's Amedisys position peaked at $97.4M in Q3 2021.
285 funds tracked by Wall St. Rank held Amedisys as of Q3 2024.

Based on D.E. Shaw & Co's 13F filing for Q3 2024, filed 14 Nov 2024.